The Journal of Minimally Invasive Gynecology
Volume 16, Issue 5 , Pages 533-539, September 2009

Aromatase Inhibitors: Potential Reproductive Implications

  • Mohamed A. Bedaiwy, MD, PhD
  • ,
  • Noha A. Mousa, MD
  • ,
  • Robert F. Casper, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Robert F. Casper, MD, Division of Reproductive Sciences and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Ave, Rm 876, Toronto, ON M5G 1X5, Canada.

University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, and Samuel Lunenfeld Research Institute, Mount Sinai Hospital and the University of Toronto, Toronto, Ontario M5G 1X5, Canada

Received 10 March 2009; accepted 12 May 2009. published online 16 July 2009.

Abstract 

MEDLINE, EMBASE, Scopus, and Web of Science databases literature search from inception to March 2009 was performed to identify published clinical trials and cohort, observational, and in vitro studies that evaluated the use of aromatase inhibitors in reproductive medicine for indications other than ovulation induction. Aromatase inhibitors are currently being investigated for breast cancer prevention in women at high risk. Aromatase inhibitors may be used for treatment of symptomatic myomas and endometriosis as an alternative to surgical intervention. Current evidence does not support the routine use of aromatase inhibitors for these conditions without prospective controlled trials. Aromatase inhibitor cotreatment can be used to prevent the initial estrogen flare effect of gonadotropin-releasing hormone agonist treatment to offer flexibility in initiating this therapy.

Keywords: Anastrazole, Aromatase inhibitors, Bone loss, Breast cancer, Endometriosis, Exemstane, GnRh antagonists and flare phenomenon, Hormone therapy, Intracrinology, Letrozole, Myomas

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(09)00250-7

doi:10.1016/j.jmig.2009.05.009

The Journal of Minimally Invasive Gynecology
Volume 16, Issue 5 , Pages 533-539, September 2009